Related Experiment Videos
[CA 19-9 like epitope(s) on carcinoembryonic antigen molecules]
Radioisotopes
|December 1, 1989
Summary
Carcinoembryonic antigen (CEA) contains CA 19-9-like epitopes, likely within its sugar structures. This finding was determined using a novel hybrid immunoradiometric-assay (hybrid IRMA) for cancer biomarker research.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Context:
- Carcinoembryonic antigen (CEA) is a known tumor marker.
- The CA 19-9 antigen is another important biomarker, particularly for gastrointestinal cancers.
- Understanding the relationship between different tumor markers can improve diagnostic strategies.
Purpose:
- To investigate the presence and nature of CA 19-9 epitope(s) on carcinoembryonic antigen (CEA).
- To characterize the structural basis of CA 19-9-like epitopes on CEA using biochemical treatments.
- To explore the potential of CEA as a carrier for CA 19-9-like structures in cancer diagnostics.
Summary:
- A hybrid immunoradiometric-assay (hybrid IRMA) was developed using anti-CEA antibodies and radio-labeled anti-CA 19-9 (NS 19-9) antibody.
- The assay detected differential radioactivities in sera from cancer patients compared to normal individuals.
- Enzymatic and chemical treatments (neuraminidase, periodate) reduced binding, suggesting the epitopes are located on CEA's sugar moieties, while PI-PLC treatment had no effect.
Impact:
- Suggests that CEA sugar structures may bear CA 19-9-like epitopes.
- Provides insights into the molecular composition of tumor-associated antigens.
- May inform the development of more specific and sensitive diagnostic tools for various cancers.